TokenPost·
Biohaven Plans Pivotal Trial for Cancer Candidate BHV-1530 by 2027

The company announced early-stage trial data for the antibody-drug conjugate on Nov. 19.
Every crypto headline. One feed. Updated every minute.

The company announced early-stage trial data for the antibody-drug conjugate on Nov. 19.